Goldman Sachs Group Inc Effector Therapeutics Inc Transaction History

Goldman Sachs Group Inc

  • $580 Billion
  • Q2 2024

A detailed history of Goldman Sachs Group Inc transactions in Effector Therapeutics Inc stock. As of the latest transaction made, Goldman Sachs Group Inc holds 630,539 shares of EFTRW stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
630,539
Previous 630,539 -0.0%
Holding current value
$0
Previous $88,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

May 14, 2024
BUY
$0.08 - $0.28 $10,000 - $35,000
125,000 Added 24.73%
630,539 $128,000
Q3 2022

Nov 10, 2022
BUY
$0.08 - $0.28 $10,000 - $35,000
125,000 Added 24.73%
630,539 $0
Q2 2022

May 14, 2024
SELL
$0.12 - $0.43 $15,000 - $53,750
-125,000 Reduced 19.82%
505,539 $101,000
Q4 2021

Feb 14, 2022
SELL
$0.7 - $1.77 $1,571 - $3,973
-2,245 Reduced 0.44%
505,539 $445,000
Q3 2021

Nov 10, 2021
BUY
$0.57 - $2.25 $289,436 - $1.14 Million
507,784 New
507,784 $812,000

Others Institutions Holding EFTRW

# of Institutions
15
Shares Held
2.85M
Call Options Held
72.7K
Put Options Held
0
View Full List

About EFFECTOR THERAPEUTICS INC

EFTRW Quotes by TradingView
  • Ticker EFTRW
More about EFTRW
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email